Cargando…
New class of agents for treatment of hypertension: focus on direct renin inhibition
Aliskiren, the first orally active direct renin inhibitor, is an effective antihypertensive drug with distinctive characteristics, including good blockade of the renin-angiotensin system, a prolonged duration of action, pharmacologic effects that persist after drug discontinuation, and favorable tol...
Autores principales: | Fogari, Roberto, Zoppi, Annalisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952455/ https://www.ncbi.nlm.nih.gov/pubmed/20957132 http://dx.doi.org/10.2147/VHRM.S4189 |
Ejemplares similares
-
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
por: Fogari, Roberto, et al.
Publicado: (2010) -
Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007) -
Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
por: Bosone, Daniele, et al.
Publicado: (2016) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008) -
Low renin hypertension
por: Sahay, Manisha, et al.
Publicado: (2012)